The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.
U. Ballehaninna,
R. Chamberlain
|
9 |
2012 |
9
2012
|
Colorectal carcinoma: Pathologic aspects.
M. Fleming,
Sreelakshmi Ravula,
S. Tatishchev,
Hanlin L. Wang
|
9 |
2012 |
9
2012
|
Gastric cancer: Classification, histology and application of molecular pathology.
Bing-qiang Hu,
N. El Hajj,
S. Sittler,
N. Lammert,
R. Barnes,
A. Meloni-Ehrig
|
9 |
2012 |
9
2012
|
Gastrointestinal stromal tumor.
Xiaohui Zhao,
Changjun Yue
|
8 |
2012 |
8
2012
|
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy.
Dae Won Kim,
Chetasi Talati,
R. Kim
|
8 |
2017 |
8
2017
|
Gastrointestinal stromal tumors: a comprehensive review.
10 auth.
Trisha M Parab,
Michael J. DeRogatis,
A. M. Boaz,
Salvatore A. Grasso,
P. Issack,
D. Duarte,
...
O. Urayeneza,
S. Vahdat,
J. Qiao,
G. Hinika
|
7 |
2018 |
7
2018
|
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.
16 auth.
D. Fabrizio,
T. George,
R. Dunne,
G. Frampton,
James X. Sun,
Kyle Gowen,
Mark Kennedy,
J. Greenbowe,
A. Schrock,
A. Hezel,
...
J. Ross,
P. Stephens,
Siraj M. Ali,
V. Miller,
M. Fakih,
S. Klempner
|
7 |
2018 |
7
2018
|
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.
11 auth.
Dongyun Yang,
A. Hendifar,
Cosima Lenz,
K. Togawa,
F. Lenz,
G. Lurje,
...
A. Pohl,
T. Winder,
Y. Ning,
S. Groshen,
H. Lenz
|
7 |
2011 |
7
2011
|
Exosome can prevent RNase from degrading microRNA in feces.
7 auth.
Y. Koga,
M. Yasunaga,
Y. Moriya,
T. Akasu,
S. Fujita,
Seiichiro Yamamoto,
...
Y. Matsumura
|
7 |
2011 |
7
2011
|
Impact of the immune system and immunotherapy in colorectal cancer.
J. Markman,
S. Shiao
|
7 |
2014 |
7
2014
|
BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies.
C. Clarke,
E. Kopetz
|
7 |
2015 |
7
2015
|
Health disparities in colorectal cancer among racial and ethnic minorities in the United States.
C. Jackson,
M. Oman,
Aatish Patel,
K. Vega
|
7 |
2016 |
7
2016
|
Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review.
A. Boscoe,
C. Rolland,
R. Kelley
|
7 |
2019 |
7
2019
|
The gut microbiome and colorectal cancer: a review of bacterial pathogenesis.
Jessica D. Dahmus,
Drew L. Kotler,
David M. Kastenberg,
C. Andrew Kistler
|
7 |
2018 |
7
2018
|
